• Welcome to the Summit by Lisa Johnson, CEO, BioForward
• Introduction t by Scott Walker Governor of Wisconsin

Healthcare Disrupted: Next Generation Business Models and Strategies

Mark Freitas is Managing Director, Patient Health & Competitive Center of Excellence, Accenture Strategy

Mark Freitas is Managing Director, Patient Health & Competitive Center of Excellence within Accenture Strategy.His keynote will focus on the need for healthcare and related industries to respond to the shift from volume to value based payments, including new business models such as Lean Innovators, Around-the-Patient Innovators, Value Innovators, and New Health Digitals. These ideas are expanded in the book Healthcare Disrupted: Next Generation Business Models and Strategies, which was written by his Accenture colleagues.

Disrupting the Status Quo: A Wisconsin Company Showcase

Wisconsin is a world leader in manufacturing, and we have the expertise and resources to extend that reputation into biomanufacturing. Hear from leaders from industry and academia about how Wisconsin is leading the way in biomanufacturing, regenerative medicine, and stem cell technology. Our group will share ideas on how we can make Wisconsin a recognized, world-class Center of Biomanufacturing Excellence.The global biohealth industry is evolving at a rapid pace, and many of the companies fueling these changes with disruptive ideas and technology are located right here in Wisconsin. Our local innovators will share how their products, from software to sensors to devices, are changing healthcare.

• Spaulding Clinical—Randy Spaulding, CEO (moderator)
• Forward Health—Michael Barbouche, CEO
• Propeller Health – Greg Tracy, CTO
• APN Health – Jasbir Sra, Founder
• Red Arrow Labs – Dale Mittelstaedt, President

Creating a Culture that Attracts and Retains Top Talent

Attracting talented individuals and getting them to stay is a problem of the highest priority at every company. Hear from award-winning, “Best Places to Work” in Wisconsin about how they have created corporate cultures that appeal to the most skilled and accomplished candidates in their fields.

• Anne Nimke, CEO/CoFounder, The Good Jobs (Moderator)
• Mary Jo Spiekerman, Vice President of Human Resources, Hausmann-Johnson Insurance 
• Joseph Taylor, President, Penrod
• James Dias, CEO, Wellbe

Reinventing Investment in Biohealth

From seed stage through exit, convertible debt to reverse merger, the investment strategy, source of funding, and structure of the deal is critical. This panel will focus on helping you think through the variety of options available to fund your company, and the key factors that influence success.

• Barbara Nelsen, Founder ,Nelsen Biomedical (Moderator)
• Matthew Cienkus, Director, Mergers & Acquisitions, Abbott Laboratories 
• Allen Hakimi, Managing Director, Technomark Life Sciences

Scientific and Business Achievement Awards

In 2015, BioForward launched the tradition of recognizing, on an annual basis, scientific and business achievements in biohealth. As we look to the future, we reflect back on the successes that have brought Wisconsin to be among the leaders in healthcare. Our recipients in 2015, captured Wisconsin’s broad impact on global human health, and additionally, their scientific and business contributions have had a significant impact on Wisconsin’s economy. Don’t miss the 2016 Biohealth Summit lunch as we recognize our 2016 awardees, highlighting their major contributions to Wisconsin and to our biohealth community.

Dr. James Thomson, Morgridge Institute 2016 Hector F. DeLuca Scientific Achievement Award Recipient  Dr. Thomson serves as Director of Regenerative Biology, at the Morgridge Institute for Research. In 2007, his lab reported (contemporaneously with Dr. Shinya Yamanaka) the first isolation of human induced pluripotent (iPS) stem cells. iPS cells have the basic properties of human ES cells but are derived from somatic cells rather than human embryos.  Dr. Thomson, also founded Cellular Dynamics, a Madison, WI based company acquired by FUJIFILM in March 2015.

Ralph Kauten, Lucigen 2016 Biohealth Business Achievement Award Recipient Ralph Kauten’s involvement in biotechnology started in 1979 at Promega Corporation followed by playing vital roles in PanVera Corporation, Mirus Bio Corporation, Quintessence Biosciences, Inc. and he currently serves as the CEO of Lucigen Corporation.

Wisconsin: A Biomanufacturing Center of Exellence

Wisconsin is currently a world leader in manufacturing, and we have the expertise and resources to extend that reputation into biomanufacturing. Hear from leaders in both academia and industry on how Wisconsin is leading the way in biomanufacturing, regenerative medicine, and stem cell technology and how we can make Wisconsin a recognized, world-class Center of Biomanufacturing Excellence. Discover how research institutions, biohealth companies, and manufacturing plants are collaborating across the state to explore the next frontier of medicine and manufacturing.

• Tom Foti, Vice President & General Manager, Aldevron (Moderator)
• William Murphy, Co-Director, Stem Cell and Regenerative Medicine Center at the University of Wisconsin-Madison
• Derek Hei, Vice President of Clinical Manufacture, Quality and Regulatory, Fujifilm-CDI
• Matt Jennings, CEO, Phillips-Medisize

Why Healthcare? Leading Technology Companies Target Healthcare Solutions

Many global leaders in technology have made the decision to devote resources and acquire new assets so they may enter and compete in a sometimes completely unexpected field, healthcare. We have gathered leaders from some of these companies to discuss why the decision was made to focus on healthcare, how easy or difficult that transition period has been, what they see in store for the future of healthcare, and how their company will lead in the creation of the next generation of healthcare solutions.

• Bruce Novich, Division President of Fujifilm North America
• Steven Tolle, CSO of IBM Watson Health Imaging
• Andrew Opichka, Healthcare Information Technology Business Transformation Architect of Cisco

Pharmaceutical Hot Topics: How Patient Centered Care is Driving Change and Propelling Opportunity

Hear from a panel of pharmaceutical experts on how understanding the needs of an empowered patient population is impacting everything from regulatory strategy and drug development to product commercialization and patient support

• Eric Floyd, Chief Scientific Officer, The Dohmen Company
• Dan Brennan, Special Advisor, Georgetown Translational Therapeutics
• Tim Cunniff, Executive Vice President – R&D, Marathon Pharmaceuticals
• Erik Eglite, Vice President, Chief Compliance Officer & Corporate Counsel, Marathon Pharmaceuticals

Cancer Moonshot to Clinical Trials: Breakthrough Approaches in the Fight Against Cancer

Followed by a Cancer Survivor Story: Samantha Mergen

This session examines the new approaches and technology being used to study, detect, and treat cancer. Hear how global leaders in pharmaceuticals and digital health are collaborating with academic researchers, hospital systems, and the biohealth industry to uncover new paths to improving patient outcomes. We have the opportunity to hear from a cancer survivor about what “improved outcomes” truly mean to patients. 

PhRMA to present their Economic Impact Study on Clinical Trials in Wisconsin as an introduction

• Umberto Tachinardi, Chief Information Officer, UW Health, Carbone Cancer Center (Moderator)
• Chorom Pak, President & Founder, Lynx Bio
• Andy DeLaO, Marketing Director, GE Healthcare